Experimental Treatment For COPD In Development
Links shared publicly online about this topic.
- 366total visits
Experimental Treatment For COPD In Development
View full resource at medicalnewstoday.com
Tags: Immune, Lung, COPD, Public Health, Healthy Living, Johns Hopkins Hospital, Education
Most Recently Shared on April 14, 2011 at 1:05 pm By:
Experimental Treatment For COPD In Development http://mnt.to/3TDz #nutrition
Also Shared By:
Abbott hepatitis drug 93% effective in small study - chicagotribune.com
chicagotribune.com — “A combination of experimental oral hepatitis C treatments being developed by Abbott Laboratories led to cure rates of more than 90 percent in previously untreated patients, according to data from a small mid-stage study.” View full resource at chicagotribune.com
Most Recently Shared on April 4, 2012 at 2:57 pm By:
John Carroll Health Communicator
Abbott is wowing the crowd with hep C data. from Reuters: http://t.co/6NZkH69v
Glaxo Lifts Theravance Stake - WSJ.com
online.wsj.com — “GlaxoSmithKline underscored how important the experimental drug Relovair is for its future by lifting its stake in the lung treatment's U.S.-based developer Theravance.” View full resource at online.wsj.com
Most Recently Shared on April 2, 2012 at 3:56 pm By:
Glaxo Lifts Theravance Stake http://t.co/4Nnxuf5S
Biotie Courted by Potential Partners for Alzheimer’s Drug - Bloomberg
bloomberg.com — “Biotie Therapies Oyj, the drugmaker that developed an anti-alcoholism medicine with H. Lundbeck A/S, has been approached by multiple potential partners for its experimental treatment for Alzheimer’s disease, Chief Executive Officer Timo Veromaa said.” View full resource at bloomberg.com
Most Recently Shared on February 20, 2012 at 3:03 pm By:
Alzheimer's Reading Room is the number one source of life news for the entire Alzheimer's community. Our goal is to Educate, sometimes Entertain, and Empower Alzheimers caregivers and their families worldwide.
" /> Alzheimer's Reading Room Health Advocate
Biotie Being Courted by Potential Partners for Alzheimer's Drug http://t.co/qwyQ6AZy #alzheimers #news
New Medical Strides Against Prostate Cancer - WSJ.com
online.wsj.com — “Researchers said an experimental prostate-cancer drug from Medivation extended survival by nearly five months in a study. A second drug, developed by Bayer and Algeta, improved survival in a separate study.” View full resource at online.wsj.com
Most Recently Shared on February 1, 2012 at 5:43 pm By:
FasterCures Health Organization
Important gains in prostate cancer research; "unprecedented" gains for patients. http://t.co/zCRrBaot
New Vaccine Approach Discovered For The Treatment Of Cancer
medicalnewstoday.com — “Scientists in Trinity College Dublin, Ireland, have developed a new vaccine to treat cancer at the pre-clinical level. The research team led by Professor Kingston Mills, Professor of Experimental” View full resource at medicalnewstoday.com
Most Recently Shared on January 30, 2012 at 9:06 am By:
New Vaccine Approach Discovered For The Treatment Of Cancer http://t.co/ymfvBvd3 #prostate
Discovery of new vaccine approach for treatment of cancer
medicalxpress.com — “(Medical Xpress) -- Scientists in Trinity College Dublin, Ireland, have developed a new vaccine to treat cancer at the pre-clinical level. The research team led by Professor Kingston Mills, Professor of Experimental Immunology at Trinity College Dublin discovered a new approach for treating the disease ...” View full resource at medicalxpress.com
Most Recently Shared on December 21, 2011 at 2:59 pm By:
PhysOrg Health News Health News
Discovery of new vaccine approach for treatment of cancer http://t.co/9LvE11XU
Targacept Slumps as Depression Drug Developed With AstraZeneca Misses Goal - Bloomberg
bloomberg.com — “Targacept Inc., developer of an experimental depression treatment with AstraZeneca Plc., plunged 36 percent after the drug failed to meet the main goal of a second trial.” View full resource at bloomberg.com
Most Recently Shared on December 20, 2011 at 6:23 pm By:
Depression Wisdom OW Health and Active Health Library
Targacept Slumps as Depression Drug Developed With AstraZeneca Misses Goal: Targacept Inc., (TRGT) developer of ... http://t.co/7DQZapMg
Genetic testing could allow personalised cancer care - Health News - NHS Choices
nhs.uk — “A new initiative to develop ‘personalised cancer treatment’ has today been launched. The experimental project has been designed to develop a screening program to test tumours for key genetic changes...” View full resource at nhs.uk
Most Recently Shared on November 22, 2011 at 12:33 am By:
Catherine Saxelby - Foodwatch Dietitian and Nutritionist
New from NHS: Charity launches major cancer genetics project http://t.co/aP9EGtKG
Drug Based on Cancer Treatment Shows Promise for Weight Loss – TIME Healthland
healthland.time.com — “An experimental drug developed from cancer research showed early promise in a study of weight loss, researchers report, causing fat monkeys to shed an average 11% of their body weight after just a month of treatment.” View full resource at healthland.time.com
Most Recently Shared on November 10, 2011 at 9:23 pm By:
Luis Saldana Doctor, Emergency Physician, and Physician
Drug Based on Cancer Treatment Shows Promise for Weight Loss http://t.co/DvU52eW4
Psoriasis Better Treated by New Experimental Drug | ThirdAge
thirdage.com — “A new drug developed for psoriasis is treating the skin condition more effectively than the leading prescribed drug, but contains more side effects.” View full resource at thirdage.com
Most Recently Shared on October 27, 2011 at 4:12 pm By:
Psoriasis Better Treated by New Experimental Drug http://t.co/T9SVWCAO
Kissei Pharmaceutical to support MN-221 development programme - Pharmaceutical Technology
pharmaceutical-technology.com — “Japan's Kissei Pharmaceutical said it will pay MediciNova $2.5m to support further clinical development of MN-221 for the treatment of acute exacerbations of asthma or chronic obstructive pulmonary disease (COPD).MN-221 is a novel, highly...” View full resource at pharmaceutical-technology.com
Most Recently Shared on October 19, 2011 at 10:31 pm By:
OrganizedWisdom COPD OW Health
Kissei Pharmaceutical to support MN-221 development programme: Japan's Kissei Pharmaceutical said it will pay Me... http://t.co/rfWxUWyd
Gantenerumab Reduces Amyloid Levels In Alzheimer's Disease Patients - QualityPoint Technologies
qualitypointtech.net — “Patients with Alzheimer's disease who were given experimental medication gantenerumab experienced reductions in brain amyloid levels, researchers from Roche, Switzerland, reported in the journal Archives of Neurology. The authors stressed theirs was a small study which will need further confirmation with larger studies. Gantenerumab is a fully human anti-Aβ monoclonal antibody in clinical development for the treatment of Alzheimer disease. Gantenerumab's chemical formula is C6496H10072N1740O202” View full resource at qualitypointtech.net
Most Recently Shared on October 11, 2011 at 2:45 am By:
Gantenerumab Reduces Amyloid Levels In Alzheimer's Disease Patients: Patients with Alzheimer's disease who were ... http://t.co/HeVG9Ff5
UPDATE 2-Roche drug shows promise in early Alzheimer's | Reuters
reuters.com — “* Phase I study could pave way for Alzheimer's treatment* Theory behind drug yet to be provenOct 10 (Reuters) - An experimental drug being developed byRoche Holding AG removed amyloid plaques from thebrains” View full resource at reuters.com
Most Recently Shared on October 10, 2011 at 9:37 pm By:
John Carroll Health Communicator
Tiny Ph1 study of Roche alzheimer's drug shows it can reduce amyloid plaque. http://t.co/PSvYXJuA
Experimental Drug Could Protect Some Cancer Patients from Radiation Side Effects, UPCI Researchers Find – UPMC, Pittsburgh, PA, USA
upmc.com — “A drug under development at the University of Pittsburgh Cancer Institute (UPCI) and the University of Pittsburgh School of Medicine could protect the cells of Fanconi anemia patients from damage caused by radiation treatment for head and neck cancers.” View full resource at upmc.com
Most Recently Shared on October 8, 2011 at 10:56 am By:
A drug can protect patients against damage caused by radiation treatment http://t.co/FvhdqqNq
Experimental drug could protect from radiatition side effects - National Cancer Institute
cancer.gov — “A drug under development at the University of Pittsburgh Cancer Institute (UPCI) and the University of Pittsburgh School of Medicine could protect the cells of Fanconi anemia patients from damage caused by radiation treatment for head and neck cancers, a” View full resource at cancer.gov
Most Recently Shared on October 7, 2011 at 5:34 pm By:
In @UPMCnews: researchers find experimental drug could offer patients protection from radiation-induced esophagitis http://j.mp/n3xSZs
Advertisement
MNT Clinical Trials
@mnt_clinical
Experimental Treatment For COPD In Development http://mnt.to/3TDz #clinicaltrials
1 year ago...